Group 1 - Dongyue Group (00189) saw a nearly 6% increase in stock price, currently at HKD 14.09 with a trading volume of HKD 302 million [1] - Market liquidity is expected to gradually return next week as companies resume operations after the Spring Festival, with demand anticipated to be released after March [1] - The refrigerant market is supported by low inventory levels and bullish expectations, maintaining high price consolidation [1] Group 2 - Export market orders are continuing to progress, and the upcoming refrigeration exhibition in April may bring new opportunities for the refrigerant market [1] - Guosen Securities indicated that the tightening of refrigerant quotas is a long-term trend, with a positive outlook for mainstream refrigerants like R32, R134a, and R125, which are expected to have significant price upside [1] - The liquid cooling industry is expected to increase demand for fluorinated liquids and refrigerants, with a recommendation to pay attention to the price recovery of fluoropolymer products like PVDF and PTFE [1]

Core Viewpoint - Dongyue Group (00189) has seen a nearly 6% increase in stock price, currently trading at 14.09 HKD with a transaction volume of 302 million HKD, driven by market expectations of recovering liquidity and demand post-Chinese New Year [1] Group 1: Market Dynamics - As companies resume production after the Chinese New Year, market liquidity is expected to gradually return next week, with spring demand anticipated to be released starting in March [1] - Current prices are supported by low inventory levels and bullish expectations, maintaining a high level of consolidation [1] Group 2: Future Outlook - Export market orders are continuing to progress, and with the upcoming refrigeration exhibition in April, multiple favorable factors may bring new opportunities for the refrigerant market, potentially leading to a new round of price support for certain products [1] - Guosen Securities previously indicated that the tightening of refrigerant quotas is a long-term trend, which supports the continued prosperity of mainstream refrigerants like R32, R134a, and R125, suggesting significant long-term price upside [1] Group 3: Industry Demand - The demand for fluorinated liquids and refrigerants is expected to increase due to the growth of the liquid cooling industry [1] - There is a recommendation to pay attention to the price recovery of fluoropolymer products such as PVDF and PTFE [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve a significant increase in net profit attributable to shareholders in 2025, with projections ranging from 3.54 billion to 3.94 billion yuan, representing a year-on-year growth of 80% to 101% [5][10] - The price of refrigerants has risen significantly, contributing to the expected growth in net profit [6][12] - The company holds a leading position in the refrigerant market, with substantial production quotas for various refrigerants, which positions it well to benefit from ongoing price increases [11][12] Financial Performance Summary - In 2025, the company anticipates a net profit attributable to shareholders of 35.40 billion to 39.40 billion yuan, with a year-on-year increase of 80% to 101% [7] - The company expects to achieve a net profit of 2.92 billion to 6.92 billion yuan in Q4 2025, reflecting a year-on-year decline of 58.42% to 1.44% [10] - The revenue from refrigerants is projected to reach 135.44 billion yuan in 2025, a year-on-year increase of 43.37% [6] Product Performance Summary - The company’s refrigerant segment is expected to generate revenue of 41.92 billion yuan in Q4 2025, with a year-on-year increase of 34.00% [9] - The average price of refrigerants is projected to be 3.95 million yuan per ton in 2025, reflecting a year-on-year increase of 47.55% [6] - The company’s fluorochemical raw materials segment is expected to generate revenue of 12.19 billion yuan, with a slight year-on-year decline of 1.23% [6] Market Position and Quotas - The company is recognized as a global leader in refrigerants, holding significant production quotas for HCFC-22 and HFCs, which account for 26.30% and 37.58% of the national market, respectively [11] - The company has a competitive edge with its fourth-generation refrigerants (HFOs), with plans to expand production capacity significantly [11]

Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company reported a significant increase in net profit for Q1 2025, driven by the high demand for refrigerants, with a year-on-year growth of 161% [1] - The refrigerant market is expected to remain strong, supported by demand from downstream sectors such as air conditioning and automotive [4] - The company is projected to achieve net profits of 41 billion, 53 billion, and 61 billion RMB for the years 2025 to 2027, respectively, indicating a robust growth trajectory [5] Revenue and Profitability - In Q1 2025, the company achieved total revenue of 5.8 billion RMB, a year-on-year increase of 6% [1] - The company's gross profit margin improved to 28.4%, reflecting a year-on-year increase of 13.7 percentage points [3] - The earnings per share (EPS) for 2025 is estimated at 1.52 RMB, with a projected growth in EPS for the following years [5] Market Performance - The average price of refrigerants has increased, with R22, R32, R125, and R134a prices rising by 9%, 13%, 7%, and 11% respectively since the beginning of the year [4] - The company's market capitalization is approximately 68.47 billion RMB, with a target price set at 31.92 RMB [9] Segment Performance - The refrigerant segment saw a year-on-year sales increase of 4%, despite a seasonal decline in Q1 [2] - The fluoropolymer segment faced temporary pressure, with a year-on-year sales decline of 7% [2] - The basic chemical products segment benefited from improved caustic soda prices, leading to a revenue increase of 7% year-on-year [3]

Core Viewpoint - The company reported a significant increase in revenue and net profit for the year 2024, driven by the recovery in the refrigerant market, and maintains a "buy" rating due to positive outlooks for future performance [1][4]. Group 1: Financial Performance - The total revenue for 2024 reached 24.5 billion yuan, representing an 18% year-over-year increase [1]. - The net profit attributable to shareholders was 1.96 billion yuan, with a year-over-year growth of 108%, and a non-recurring profit of 1.90 billion yuan, reflecting a 131% increase [1]. - In Q4 2024, the net profit attributable to shareholders was 700 million yuan, with a year-over-year increase of 257% and a quarter-over-quarter increase of 66% [1]. Group 2: Segment Performance - The refrigerant segment saw a 23% year-over-year increase in external sales volume to 353,000 tons, primarily due to the consolidation of Feiyuan Chemical and rising prices under quota systems, with average prices increasing by 33% to 26,800 yuan per ton [2]. - The fluoropolymer segment experienced an 8% year-over-year increase in sales volume to 46,000 tons, but faced price pressure, with average prices declining by 15% to 38,000 yuan per ton [2]. - The fine fluorochemical segment reported a remarkable 255% year-over-year increase in sales volume to 5,000 tons, with revenue growing by 99% to 280 million yuan [2]. Group 3: Market Outlook - The refrigerant market is expected to continue its upward trend, supported by demand from downstream sectors such as air conditioning and automotive, alongside tight supply conditions for second and third-generation refrigerants [3]. - The company is set to benefit from new projects, including FEP, Juxin cooling liquids, and fourth-generation refrigerants, which are anticipated to enhance integrated and scale advantages [3]. Group 4: Profit Forecast and Valuation - The company has revised its profit forecasts upward, expecting net profits of 4.1 billion yuan, 5.3 billion yuan, and 6.1 billion yuan for 2025-2027, reflecting increases of 8% and 14% for 2025-2026 compared to previous estimates [4]. - The target price for the company is set at 30.4 yuan based on a 20x PE ratio for 2025, up from a previous target of 28.2 yuan [4].